PatientsVille.com Logo

Reflux and Uralyt

PatientsVille

Reflux Symptoms and Causes

Your esophagus is the tube that carries food from your mouth to your stomach. Gastroesophageal Reflux disease (GERD) happens when a muscle at the end of your esophagus does not close properly. This allows stomach contents to leak back, or Reflux, into the esophagus and irritate it.

You may feel a burning in the chest or throat called heartburn. Sometimes, you can taste stomach fluid in the back of the mouth. If you have these symptoms more than twice a week, you may have GERD. You can also have GERD without having heartburn. Your symptoms could include a dry cough, asthma symptoms, or trouble swallowing.

Anyone, including infants and children, can have GERD. If not treated, it can lead to more serious health problems. In some cases, you might need medicines or surgery. However, many people can improve their symptoms by

  • Avoiding alcohol and spicy, fatty or acidic foods that trigger heartburn
  • Eating smaller meals
  • Not eating close to bedtime
  • Losing weight if needed
  • Wearing loose-fitting clothes

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Check out the latest treatments for reflux

reflux treatment research studies

Uralyt clinical trials, surveys and public health registries


Find Drug Side Effect reports



Uralyt Side Effects

Intestinal Stenosis (44)
Renal Disorder (33)
Liver Disorder (29)
Melaena (24)
Hepatic Failure (20)
Vomiting (18)
Altered State Of Consciousness (15)
Gamma-glutamyltransferase Increased (15)
Alanine Aminotransferase Increased (14)
Abdominal Pain (13)
Hypertension (12)
Toxicity To Various Agents (12)
Gait Disturbance (11)
Malignant Neoplasm Of Renal Pelvis (9)
Ileal Stenosis (9)
Ileal Ulcer (8)
Interstitial Lung Disease (5)
Platelet Count Decreased (4)
Malaise (3)
Sepsis (3)
Diarrhoea (1)
Dizziness (1)
White Blood Cell Count Decreased (1)
Conjunctival Hyperaemia (1)
Aspartate Aminotransferase Increased (1)
Cerebral Haemorrhage (1)
Cognitive Disorder (1)
Condition Aggravated (1)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

I was given Clindamycin (150 MG Capsule) to take for 10 days 4 times daily for tooth extractions aftercare. It gives me splitting headaches and acid reflux . Evdokia

Bad taste in my mouth, very bloated and abdominal pain and reflux

:( alas, tried it for one month and not good!. main problems, bloating, abdominal discomfort, reflux/heartburn,[had to try sleep sitting up], symptoms went on stopping, returned on restart, did lower my BP but too high a cost!.

About half an hour after taking Crestor I get a bad dose of reflux...which I have under control with medication.....but oh boy is it giving me a hard time. Dull aches around knee joints wake me during the night. Sinus is bad again too!

After taking Arimidex 25mg, and after Aromasin 25 mg for almost 10 years, I have developed Parkinson's, Osteopedia, Alopexia, and my shouldershave been swalen, I also gain weight, and retain a lot of fluids, I has acid reflux, until my doct

After taking Prevacid for the past 12 years for severe acid reflux (my upper sphincter does not close), I seem to have developed some resistance to it, as it only works for about 16 hours now instead of 24. This made sleeping difficult, so I started

Been on drug since 1/20/11. er mid feb w/diagnosis of acid reflux; as time went on i have had excessive gas, leg/ankle swelling; loss of appetite; dry cough; sleepiness; lack of energy; out of breath; docs say heart failure---this is an 85 yr old man

Breathing easier but acid indigestion and reflux. Cramp. I stopped taking the seretide evohaler and the terrible acid continued but got easier. The cramp has gone, thank goodness as one muscle would cramp one way and the other would cramp the other,

Burning in stimach/acid reflux

Citracal Calcium + Dwith Genistein 1200mg per day, 3 days in and excessive abdominal gas. Acid reflux also flaired back up. Since previous back injury did not associate back painwith Citracal, just assumed I had done something

Reflux Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-Reflux Surgery
Condition: Non-acid Reflux Disease
Intervention: Procedure: anti-Reflux surgery
Outcome Measure: Effectiveness of anti-Reflux surgery
2 Not yet recruiting Treatment of IPF With Laparoscopic Anti-Reflux Surgery
Conditions: Idiopathic Pulmonary Fibrosis;   Gastroesophageal Reflux
Intervention: Procedure: Surgery
Outcome Measures: Forced vital capacity (FVC);   Acid and non-acid Reflux events;   Safety of laparoscopic anti-Reflux surgery;   All-cause mortality;   Non-elective hospitalization;   Acute exacerbations;   UCSD SOQB score;   SGRQ Score;   6-minute walk distance;   Cough VAS;   HRCT fibrosis score
3 Not yet recruiting The Difference of Reflux Pattern Between the Patients Who Have Postprandial Reflux Symptoms
Condition: Gastroesophageal Reflux Disease
Intervention: Device: 24hr pH monitoring
Outcome Measures: The difference of Reflux pattern at postprandial period between the patients who have postprandial Reflux symptoms and the normal people;   The difference of esophageal Reflux pH between the patients who have postprandial Reflux symptoms and the normal people
4 Not yet recruiting Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy
Conditions: Acid Reflux Esophagitis;   Non-acid Reflux Esophagitis
Intervention: Drug: Lanreotide
Outcome Measure: Los Angeles criteria for Reflux esophagitis
5 Unknown  Prevacid vs Lifestyle Modifications for the Treatment of LPR
Condition: Laryngopharyngeal Reflux
Interventions: Drug: Prevacid 30mg BID;   Behavioral: Lifestyle changes of exercise and diet changes for weight loss and avoidance of Reflux inducing foods.
Outcome Measures: To compare the numbers of subjects with a Reflux Symptom Index score of less than 13 at visit 3;   To evaluate the changes in Reflux Finding Score and Reflux Symptom Index from initial scores at screening to final assessment at visit 3.
6 Recruiting The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis
Conditions: Esophagitis;   Reflux Esophagitis;   Gastroesophageal Reflux Disease
Intervention: Other: Cessation of Acid Suppressing Medications
Outcome Measures: change in esophageal inflammation from baseline to 14 days;   change in HIF-2a levels from baseline to 14 days
7 Recruiting Prospective Pediatric Vesicoureteral Reflux Surgery Database
Condition: Vesicoureteral Reflux
Intervention:
Outcome Measure: Resolution of vesicoureteral Reflux
8 Unknown  Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux
Condition: Laryngopharyngeal Reflux
Interventions: Drug: Sodium alginate;   Drug: Placebo
Outcome Measures: Mean reduction in the total Reflux symptom index (RSI) score from baseline to Week 8;   Mean reduction in the total Reflux symptom index (RSI) score from baseline to Day 2 and Week 4
9 Not yet recruiting The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux
Conditions: Eustachian Tube Dysfunction;   Laryngopharyngeal Reflux
Interventions: Drug: Omeprazole;   Drug: Ranitidine;   Drug: Pantoprazole;   Procedure: 24-Hour Diagnostic pH-Probe Test;   Procedure: Laryngoscopy
Outcome Measure: Evidence of laryngopharyngeal Reflux in patients complaining of ear fullness/pressure/pain
10 Recruiting The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis
Conditions: Interstitial Lung Disease;   Systemic Sclerosis;   Gastroesophageal Reflux
Intervention: Other: Gastro-esophageal Reflux
Outcome Measures: Measurements of pepsin and pH in the Exhaled breath condensate (EBC);   In a subgroup pf 40 patients, measurements of pepsin and bile salts in bronchoalveolar lavage (BAL);   Serum KL-6;   Changes from baseline in longitudinal lung function assessment
11 Unknown  Incidence of Reflux Esophagitis After Pancreaticoduodenectomy
Condition: Reflux Esophagitis
Intervention: Procedure: Methods of gastrojejunostomy reconstruction
Outcome Measures: Incidence and severity of Reflux esophagitis;   Incidenc of marginal ulcer
12 Unknown  Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD
Condition: Gastroesophageal Reflux Disease
Interventions: Drug: Esomeprazole;   Drug: esomeprazole
Outcome Measure: The Effect of Esomeprazole 40 mg. Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients w/ GERD.
13 Recruiting Laryngopharyngeal Reflux Before and After Cricopharyngeal Myotomy
Conditions: Laryngopharyngeal Reflux;   Zenker's Diverticulum
Interventions: Procedure: Cricopharyngeal myotomy;   Device: Restech's Dx-pH Probe
Outcome Measures: Presence of LPR measured by: number of pH drops >3 standard deviations from baseline and the pharyngeal composite pH score.;   Reflux symptom index (RSI) score;   Mayo Dysphagia Questionnaire Score;   Reflux finding score
14 Unknown  Gastric Accommodation and Gastroesophageal Reflux
Condition: Gastroesophageal Reflux Disease
Intervention:
Outcome Measures: NUMBER OF Reflux EPISODES;   Gastric volume ratio: 10 min/baseline
15 Recruiting Morphological Markers of Gastroesophageal Reflux Disease (GERD)
Conditions: Eosinophilic Esophagitis;   Gastroesophageal Reflux Disease
Intervention: Other: Sample collection and Questionnaire
Outcome Measures: TEM analysis;   pH monitoring
16 Recruiting Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study
Condition: Non-erosive Reflux Disease
Interventions: Drug: Esomeprazole;   Drug: Placebo
Outcome Measure: NBI endoscopy identifies changes in the distal esophagus that are specific for diagnosing patients with Non-Esophageal Reflux Disease.
17 Recruiting The Diagnostics of Extraesophageal Reflux With the Restech System
Conditions: Nasal Diseases;   Nasal Polyps;   Laryngopharyngeal Reflux
Intervention: Device: pH monitoring (Restech)
Outcome Measure: The frequency of the extraesophageal Reflux in patients with chronic rhinosisnusitis
18 Not yet recruiting Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)
Conditions: Gastroesophageal Reflux Disease;   Non Erosive Reflux Disease;   Dyspepsia
Interventions: Device: Confocal endomicroscopy;   Drug: Proton pump inhibitor;   Drug: Sucralfate
Outcome Measures: Response to NERD treatment;   Confocal endomicroscopy findings;   Quality of life
19 Recruiting Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux
Conditions: Laryngopharyngeal Reflux;   Oesophageal pH-impedance
Intervention: Drug: esomeprazole
Outcome Measures: Number of pharyngeal Reflux/24h;   • Number of pharyngeal acid Reflux/24h;   • Number of pharyngeal less acid Reflux/24h;   • Pharyngeal acid exposure (% of total time with pharyngeal pH <4);   • Pharyngeal bolus exposure (% of total time with liquid in the pharynx)
20 Recruiting Observational Study of Anti-Reflux Surgery
Condition: GERD
Intervention:
Outcome Measure: Collect data about anti-Reflux surgical treatment options (LINX Reflux Management System and Fundoplication) in everyday clinical practice